Guru Ownership Trend
Guru Analysis for Palisade Bio, Inc. (PALI)
Palisade Bio, Inc. (PALI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9.31 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $9.37 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Renaissance Technologies (RenTech) reduced exposure by 22.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Palisade Bio, Inc. (PALI)
Major holders include Steven Cohen ($10.98 M), Renaissance Technologies (RenTech) ($2.35 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 6.38 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $9.37 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited PALI. The total reported sell value was $749,895.
Yes, 0 managers opened new positions in PALI, and 1 increased their existing holdings. The total reported buy value was $10.12 M.